Reductions in the risks of recurrent stroke in patients with and without diabetes: The PROGRESS Trial

Author： Berthet Karine   Neal Bruce   Chalmers John   Macmahon Stephen   Bousser Marie   Colman Sam   Woodward Mark  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.13, Iss.1, 2004-02, pp. : 7-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Disparity in Long-Term Survival after a First Stroke in Patients with and without Diabetes Persists: The Northern Sweden MONICA Study

By  

Cerebrovascular Diseases, Vol. 34, Iss. 2, 2012-08 ,pp. : 153-160

Karger

Access to resources Recommend Favorite

Aspirin and ticlopidine for prevention of recurrent stroke in black patients

By Gorelick P.B.   Richardson D.   Kelly M.   for the African American Antiplatelet Stroke Prevention Study AAASPS Investigators.  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 30-31

Elsevier

Access to resources Recommend Favorite

Prevention of Stroke in Patients with Diabetes mellitus and the Metabolic Syndrome

By  

Cerebrovascular Diseases, Vol. 20, Iss. 1, 2005-11 ,pp. : 24-34

Karger

Access to resources Recommend Favorite

Biochemical Aspirin Resistance and Recurrent Lesions in Patients with Acute Ischemic Stroke

By  

European Neurology, Vol. 64, Iss. 1, 2010-07 ,pp. : 51-57

Karger

Access to resources Recommend Favorite

Diabetes and Stroke

By  

Cerebrovascular Diseases, Vol. 15, Iss. 2, 2003-04 ,pp. : 25-30

Karger

Access to resources Recommend Favorite